Science Explorer Back to mapMap
Institution · Saint-Denis · France

Epi-Phare

Research works
7
▼ 100% vs 2018-21
Citations
86
12.0 per fractional work
Top-10% rate
7.0%
all institutions 10.0%
Open access
20%
world 40%
International
14%
world 18%

Not ranked overall: Epi-Phare is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Epi-Phare work in?

In all years, 70% of research at Epi-Phare is in Health Sciences, 26% in Social Sciences. Its largest fields are Medicine (44%), Health Professions (26%), Social Sciences (23%). It does 1.7× the world's share of Health Sciences.

Health Sciences: 5 fractional works · 70.0% of its workMedicine: 3 fractional works · 44.4% of its workOphthalmology: 1 fractional works · 9.3% of its workPsychiatry and Mental health: 1 fractional works · 7.4% of its workEpidemiology: 0 fractional works · 6.4% of its workPathology and Forensic Medicine: 0 fractional works · 4.6% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 4.5% of its workNeurology: 0 fractional works · 3.9% of its workPharmacology: 0 fractional works · 3.9% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 2.4% of its workGeriatrics and Gerontology: 0 fractional works · 1.0% of its workOncology: 0 fractional works · 0.8% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.4% of its workHealth Professions: 2 fractional works · 25.6% of its workGeneral Health Professions: 1 fractional works · 20.6% of its workRadiological and Ultrasound Technology: 0 fractional works · 5.0% of its workSocial Sciences: 2 fractional works · 26.3% of its workSocial Sciences: 2 fractional works · 22.5% of its workDemography: 1 fractional works · 12.1% of its workSociology and Political Science: 0 fractional works · 5.8% of its workHealth: 0 fractional works · 2.4% of its workUrban Studies: 0 fractional works · 2.4% of its workBusiness, Management and Accounting: 0 fractional works · 3.5% of its workAccounting: 0 fractional works · 2.4% of its workOrganizational Behavior and Human Resource Management: 0 fractional works · 1.1% of its workPsychology: 0 fractional works · 0.3% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.3% of its workLife Sciences: 0 fractional works · 2.2% of its workNeuroscience: 0 fractional works · 1.7% of its workBiological Psychiatry: 0 fractional works · 1.0% of its workCognitive Neuroscience: 0 fractional works · 0.8% of its workImmunology and Microbiology: 0 fractional works · 0.6% of its workApplied Microbiology and Biotechnology: 0 fractional works · 0.6% of its workPhysical Sciences: 0 fractional works · 1.5% of its workEnvironmental Science: 0 fractional works · 1.5% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 1.0% of its workPollution: 0 fractional works · 0.6% of its workALL ITS WORKEpi-Phare7fractional works, all years
Life Sciences2%Physical Sciences2%Health Sciences70%Social Sciences26%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 8 fields, with their numbers
    1. Medicine344.4%
    2. Health Professions225.6%
    1. Social Sciences222.5%
    2. Business, Management and Accounting03.5%
    3. Psychology00.3%
    1. Neuroscience01.7%
    2. Immunology and Microbiology00.6%
    1. Environmental Science01.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

    Who are the top researchers at Epi-Phare?

    Ranked on the quality score, Bruno Richardot lead among researchers whose main affiliation is Epi-Phare.

    1. 1 Bruno Richardot France · #3,366,197 worldwide 1 citations · 18 works
    All ranked researchers at Epi-Phare

    What are the most cited papers from Epi-Phare?

    The most cited paper from Epi-Phare is "Significant Reduction of Antibiotic Use in the Community after a Nationwide Campaign in France, 2002–2007" (Elifsu Sabuncu, Julie David, Claire Bernède‐Bauduin et al., 2009), with 406 citations. Next come "Older age at retirement is associated with decreased risk of dementia" (72) and "Prevalence and patterns of methylphenidate use in French children and adolescents" (62).

    Most cited papers
    #PaperReleasedCitations
    1 Significant Reduction of Antibiotic Use in the Community after a Nationwide Campaign in France, 2002–2007 Elifsu Sabuncu, Julie David, Claire Bernède‐Bauduin et al. · PLoS Medicine Open access Jun 2009 406
    2 Older age at retirement is associated with decreased risk of dementia Carole Dufouil, Edwige Pereira, Geneviève Chêne et al. · European Journal of Epidemiology May 2014 72
    3 Prevalence and patterns of methylphenidate use in French children and adolescents Anne‐Laure Knellwolf, Jean Deligne, Flavia Chiarotti et al. · European Journal of Clinical Pharmacology 19 Nov 2007 62
    4 Exposure to psychotropics in the French older population living with dementia: a nationwide population‐based study Alice Breining, Dominique Bonnet‐Zamponi, Lorène Zerah et al. · International Journal of Geriatric Psychiatry 29 May 2016 29
    5 Le diabète de type 2 en France : épidémiologie, évolution de la qualité de la prise en charge, poids social et économique. Entred 2007 Céline Druet, Isabelle Bourdel‐Marchasson, Alain Weill et al. · La Presse Médicale 6 Apr 2013 25
    All 19 most cited papers, with filters and sorting

    Which research topics does Epi-Phare publish most on?

    By volume: Retirement, Disability, and Employment, Aging, Elder Care, and Social Issues, Occupational Health and Safety Research and Retinal Diseases and Treatments.

    1. 1 Retirement, Disability, and Employment Demography 1 works
    2. 2 Aging, Elder Care, and Social Issues General Health Professions 1 works
    3. 3 Occupational Health and Safety Research Radiological and Ultrasound Technology 0 works
    4. 4 Retinal Diseases and Treatments Ophthalmology 0 works
    5. 5 Ophthalmology and Visual Impairment Studies Epidemiology 0 works
    6. 6 Social Policies and Family Sociology and Political Science 0 works
    7. 7 Healthcare Systems and Practices General Health Professions 0 works
    8. 8 Health, Medicine and Society General Health Professions 0 works
    9. 9 Musculoskeletal pain and rehabilitation Pharmacology 0 works
    10. 10 Occupational exposure and asthma Public Health, Environmental and Occupational Health 0 works

    How open and international is its research?

    Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

    openly available20.3%not open79.7%

    World: 40% of research is openly available.

    with international co-authors13.6%domestic only86.4%

    World: 18% is written across borders.

    How has Epi-Phare's research output changed?

    Output in 2022-2025 was 100% lower than in 2018-2021.

    201020152020
    grewheldshrank

    The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

    Its share of all research

    Growing output can still be a shrinking share: all of science grows. This is Epi-Phare as a percentage of every work published that year, 0.000012% in 2018.

    0.000020%0.000040%0.000060%Epi-Phare0.0000039% in 202120102020

    Fractional works of Epi-Phare over all fractional works that year. How the balance of science has shifted.

    Other research institutions in Saint-Denis

    All research institutions in Saint-Denis

    Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

    Discussion

    Ask a question or share a note about Epi-Phare. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.